Success Metrics

Completion Rate
0%(0/1)
Active Trials
2(50%)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Terminated(1)

Detailed Status

Active, not recruiting2
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
0.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

not_yet_recruiting125%
terminated125%
active_not_recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
active_not_recruiting

TO-ChERIsH: Trajectory of Cardiovascular Ageing, Its Determinants and Impact on Health

NCT04501562
not_yet_recruitingnot_applicable

Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients

NCT06772350
active_not_recruitingnot_applicable

Cardiovascular Risk and Chronic Inflammatory Rheumatism

NCT03187444
terminated

Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease

NCT00946361

Clinical Trials (4)

Showing 4 of 4 trials
NCT04501562

TO-ChERIsH: Trajectory of Cardiovascular Ageing, Its Determinants and Impact on Health

Active Not Recruiting
NCT06772350Not Applicable

Role of Altered Intestinal Permeability and Lipopolysaccharide in Thrombotic Risk and Vascular Injury in IBD Patients

Not Yet Recruiting
NCT03187444Not Applicable

Cardiovascular Risk and Chronic Inflammatory Rheumatism

Active Not Recruiting
NCT00946361

Impaired Insulin-like Growth Factor-1 (IGF-1) Generation Causes Protein Catabolism and Poor Growth in Children With Crohn Disease

Terminated

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4